Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,039 | 325 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $708.88 | 41 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $672.00 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $504.01 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $378.59 | 22 | $0 (2024) |
| Novo Nordisk Inc | $366.54 | 25 | $0 (2022) |
| ABBVIE INC. | $307.29 | 30 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $256.87 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $201.06 | 14 | $0 (2024) |
| PFIZER INC. | $194.13 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $143.02 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $341.90 | 19 | Xeris Pharmaceuticals, Inc. ($67.38) |
| 2023 | $363.42 | 20 | AstraZeneca Pharmaceuticals LP ($76.28) |
| 2022 | $627.77 | 34 | Amgen Inc. ($116.15) |
| 2021 | $1,252 | 88 | AbbVie Inc. ($253.31) |
| 2020 | $933.20 | 59 | AstraZeneca Pharmaceuticals LP ($192.02) |
| 2019 | $406.56 | 27 | Amgen Inc. ($81.22) |
| 2018 | $493.42 | 34 | Amgen Inc. ($112.69) |
| 2017 | $626.48 | 45 | AstraZeneca Pharmaceuticals LP ($109.43) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Oncology | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 07/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Endocrinology | ||||||
| 05/21/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Analgesic | ||||||
| 04/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: DIABETES | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.20 | General |
| 12/12/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $25.54 | General |
| 09/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Oncology | ||||||
| 08/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DEVICE | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 841 | 2,796 | $170,200 | $90,092 |
| 2022 | 15 | 1,235 | 3,266 | $198,926 | $106,334 |
| 2021 | 17 | 1,100 | 2,586 | $137,474 | $75,971 |
| 2020 | 15 | 904 | 2,826 | $160,290 | $76,840 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 596 | $89,400 | $48,394 | 54.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 159 | $31,800 | $19,026 | 59.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $13,650 | $10,963 | 80.3% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 62 | 316 | $13,272 | $3,033 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 271 | $2,710 | $2,276 | 84.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 100 | 554 | $7,202 | $2,133 | 29.6% |
| 92552 | Test for hearing various pitches using earphone | Office | 2023 | 101 | 103 | $3,811 | $2,021 | 53.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 37 | 75 | $2,100 | $926.25 | 44.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 55 | $1,870 | $541.32 | 28.9% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 43 | 185 | $2,220 | $429.20 | 19.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,222 | $245.41 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 21 | $210.00 | $71.61 | 34.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 344 | $732.72 | $32.03 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 561 | $84,150 | $46,714 | 55.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 142 | 256 | $51,200 | $29,036 | 56.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 125 | 125 | $18,750 | $15,681 | 83.6% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2022 | 105 | 362 | $15,204 | $3,685 | 24.2% |
| 92552 | Test for hearing various pitches using earphone | Office | 2022 | 141 | 144 | $5,328 | $2,826 | 53.0% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 132 | 547 | $7,111 | $2,122 | 29.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,392 | $2,098 | 87.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 61 | 118 | $3,304 | $1,473 | 44.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 150 | 312 | $3,120 | $924.99 | 29.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 46 | 79 | $2,686 | $721.43 | 26.9% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 59 | 179 | $2,148 | $418.58 | 19.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 30 | $1,410 | $281.60 | 20.0% |
About Dr. Robin Rodgers, MD
Dr. Robin Rodgers, MD is a Family Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811958309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Rodgers, MD has received a total of $5,044 in payments from pharmaceutical and medical device companies, with $341.90 received in 2024. These payments were reported across 326 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,039).
As a Medicare-enrolled provider, Rodgers has provided services to 4,080 Medicare beneficiaries, totaling 11,474 services with total Medicare billing of $349,237. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cartersville, GA
- Active Since 04/01/2006
- Last Updated 11/03/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811958309
Products in Payments
- FARXIGA (Drug) $591.76
- TRELEGY ELLIPTA (Drug) $352.11
- Ozempic (Drug) $298.01
- JARDIANCE (Drug) $267.37
- VRAYLAR (Drug) $224.00
- ENTRESTO (Drug) $213.54
- Aimovig (Biological) $210.49
- EVENITY (Biological) $198.06
- Otezla (Drug) $154.45
- Kerendia (Drug) $133.02
- UBRELVY (Drug) $122.37
- CHANTIX (Drug) $120.83
- Prolia (Biological) $119.83
- XARELTO (Drug) $103.10
- Cologuard Collection Kit (Device) $93.87
- Myrbetriq (Drug) $82.54
- Dayvigo (Drug) $82.50
- STIOLTO RESPIMAT (Drug) $79.93
- BELSOMRA (Drug) $78.50
- NEXLETOL (Drug) $67.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cartersville
Louis Spencer, M.d, M.D
Family Medicine — Payments: $12,393
Dr. Carl Bevill, Md, MD
Family Medicine — Payments: $12,235
Mary Barfield, Md, MD
Family Medicine — Payments: $7,612
Mr. Lee Battle, Md, MD
Family Medicine — Payments: $6,097
Dr. James Williams, Md, MD
Family Medicine — Payments: $5,932
Dr. Richard Britton, D.o, D.O
Family Medicine — Payments: $5,359